Cutera Future Growth
Future criteria checks 0/6
Cutera is forecast to grow earnings and revenue by 33.2% and 2.9% per annum respectively while EPS is expected to grow by 31.9% per annum.
Key information
33.2%
Earnings growth rate
31.9%
EPS growth rate
Medical Equipment earnings growth | 16.4% |
Revenue growth rate | 2.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 22 Mar 2024 |
Recent future growth updates
Recent updates
Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive
Mar 14Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be
Aug 11An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued
Apr 19Does Cutera (NASDAQ:CUTR) Have A Healthy Balance Sheet?
Jan 11Would Cutera (NASDAQ:CUTR) Be Better Off With Less Debt?
Oct 06Cutera: Shares Very Attractively Priced, Top-Line Hedged From CMS
Sep 08Cutera, Inc. (NASDAQ:CUTR) Shares Could Be 49% Below Their Intrinsic Value Estimate
Sep 01Cutera: The 'AviClear' Sign To Get Bullish
Jun 22Cutera (NASDAQ:CUTR) Is Carrying A Fair Bit Of Debt
May 27Returns On Capital Signal Tricky Times Ahead For Cutera (NASDAQ:CUTR)
Apr 22Cutera: Gains Aren't Surprising After Acne Laser Therapy Cleared
Mar 31What Does Cutera, Inc.'s (NASDAQ:CUTR) Share Price Indicate?
Feb 23We Think Cutera (NASDAQ:CUTR) Can Stay On Top Of Its Debt
Jan 08Revisiting Cutera
Dec 18We Like These Underlying Return On Capital Trends At Cutera (NASDAQ:CUTR)
Nov 30Is Cutera (NASDAQ:CUTR) A Risky Investment?
Sep 17Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 195 | -54 | N/A | N/A | 3 |
12/31/2025 | 178 | -87 | N/A | N/A | 5 |
12/31/2024 | 163 | -131 | N/A | N/A | 5 |
12/31/2023 | 212 | -151 | -171 | -138 | N/A |
9/30/2023 | 230 | -113 | -160 | -121 | N/A |
6/30/2023 | 247 | -81 | -146 | -105 | N/A |
3/31/2023 | 249 | -92 | -108 | -74 | N/A |
12/31/2022 | 252 | -82 | -90 | -67 | N/A |
9/30/2022 | 251 | -78 | -62 | -47 | N/A |
6/30/2022 | 245 | -68 | -43 | -34 | N/A |
3/31/2022 | 240 | -13 | -31 | -30 | N/A |
12/31/2021 | 231 | 2 | 0 | 1 | N/A |
9/30/2021 | 216 | 8 | 2 | 3 | N/A |
6/30/2021 | 197 | 7 | 5 | 6 | N/A |
3/31/2021 | 165 | -12 | -5 | -4 | N/A |
12/31/2020 | 148 | -24 | -18 | -17 | N/A |
9/30/2020 | 150 | -28 | -19 | -17 | N/A |
6/30/2020 | 157 | -29 | -17 | -16 | N/A |
3/31/2020 | 178 | -17 | -7 | -6 | N/A |
12/31/2019 | 182 | -12 | -3 | -2 | N/A |
9/30/2019 | 175 | -37 | 1 | 2 | N/A |
6/30/2019 | 170 | -35 | 2 | 3 | N/A |
3/31/2019 | 165 | -37 | 1 | 2 | N/A |
12/31/2018 | 163 | -31 | -1 | 0 | N/A |
9/30/2018 | 165 | 18 | -3 | -1 | N/A |
6/30/2018 | 162 | 25 | 3 | 4 | N/A |
3/31/2018 | 156 | 29 | 7 | 8 | N/A |
12/31/2017 | 151 | 30 | 13 | 14 | N/A |
9/30/2017 | 142 | 11 | N/A | 12 | N/A |
6/30/2017 | 134 | 7 | N/A | 10 | N/A |
3/31/2017 | 125 | 4 | N/A | 2 | N/A |
12/31/2016 | 118 | 3 | N/A | 2 | N/A |
9/30/2016 | 110 | 0 | N/A | 1 | N/A |
6/30/2016 | 103 | -2 | N/A | -1 | N/A |
3/31/2016 | 98 | -3 | N/A | 1 | N/A |
12/31/2015 | 95 | -4 | N/A | -1 | N/A |
9/30/2015 | 90 | -8 | N/A | -5 | N/A |
6/30/2015 | 86 | -10 | N/A | -5 | N/A |
3/31/2015 | 81 | -11 | N/A | -9 | N/A |
12/31/2014 | 78 | -11 | N/A | -4 | N/A |
9/30/2014 | 75 | -9 | N/A | -2 | N/A |
6/30/2014 | 73 | -8 | N/A | -1 | N/A |
3/31/2014 | 75 | -6 | N/A | 3 | N/A |
12/31/2013 | 75 | -5 | N/A | 4 | N/A |
9/30/2013 | 75 | -3 | N/A | 4 | N/A |
6/30/2013 | 77 | -3 | N/A | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CUTR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CUTR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CUTR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CUTR's revenue (2.9% per year) is forecast to grow slower than the US market (7.9% per year).
High Growth Revenue: CUTR's revenue (2.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CUTR's Return on Equity is forecast to be high in 3 years time